Wilhelminen Hospital

Publications

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

John W. Eikelboom , Lars Wallentin , Stuart J. Connolly +13 more

Background— Dabigatran 150 and 110 mg twice a day and warfarin are effective for stroke prevention in atrial fibrillation. The purpose of this study was to compare their risks o...

2011 Circulation 1071 citations

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

John H. Alexander , Renato D. Lópes , Stefan James +31 more

The addition of apixaban, at a dose of 5 mg twice daily, to antiplatelet therapy in high-risk patients after an acute coronary syndrome increased the number of major bleeding ev...

2011 New England Journal of Medicine 990 citations

Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries

Steen Dalby Kristensen , Kamilla Grønborg Laut , Jean Fajadet +97 more

Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not ...

2014 European Heart Journal 342 citations

Institution Info

Type: healthcare
Country: AT
Publications: 3
Citations: 2,403

External Links

Identifiers

ROR: https://ror.org/00qcsrr17

Publications

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries

Affiliated Researchers

Mike Ezekowitz

Scott Kaatz

Hans‐Christoph Diener

Institution Info

External Links

Identifiers